Scaffold Technology Market Segmentation:
Type Segment Analysis
The hydrogels segment in the scaffold technology market is poised to capture a share of 40.2% in the coming years, impacting the sector's scaffold technology landscape. Significant growth in the revenue share is anticipated owing to the properties it offers while using it such as easy drug and cell loading for controlled drug delivery. Moreover, the advanced technologies in this field support the market growth. For instance, in March 2021, Bio-Techne Corporation released Cultrex UltiMatrix for culturing pluripotent stem cells as they slow down the Basement Membrane Extract (BME) growth factor. It is a cutting-edge matrix hydrogel with enhanced tensile strength and the ideal extracellular matrix protein composition for regenerative medicine, personalized medicine, and drug discovery studies. Growth in this sector will boost the drug delivery devices value in the near future.
Application Segment Analysis
The stem cell therapy, tissue engineering & regenerative medicine segment is expected to be the fastest-growing segment with a lucrative size by the end of the forecast period. This growth is propelled by the increased usage of scaffolding technologies in colorectal procedures, reconstruction and aesthetic surgeries, tumor repair, soft tissue, and periodontology. Furthermore, researchers have been highly attracted to the diverse use of scaffold technology in the field of regenerative medicine in recent years. In addition, a German biotech company Co. don AG, was fully acquired by ReLive Biotechnologies, Ltd in Jan 2023. Credited to this, ReLive was able to carry out independent research and create affordable tissue-engineered products using 3D printing and stem cell technology.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Application |
|
|
End User |
|
|
Disease Type |
|
